Skip to main content
Erschienen in:

19.12.2023 | Review Article

OOPHORECTOMY: When and Why? A Novel Risk Stratification Tool as an Aid to Decision Making at Gynecological Surgeries

verfasst von: Suvarna Satish Khadilkar, Meena Samant

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

The decision regarding oophorectomy during gynecological surgeries, especially in perimenopausal and postmenopausal women, has historically posed a significant dilemma. Traditionally, it was widely believed that conserving the ovaries held no benefits, leading to a common practice of recommending bilateral salpingo-oophorectomy alongside hysterectomy for benign conditions in women aged 40–45 and above. Given our evolving comprehension of postmenopausal ovarian function and the genetic susceptibility to ovarian epithelial cancers, the decision regarding oophorectomy poses a dilemma. Oophorectomy is recommended for women with a higher risk of ovarian cancer and ovarian conservation is necessary with women with higher risk of co-morbidities. This paper reviews the available literature on these aspects of oophorectomy. Despite a wealth of literature narrating the advantages and disadvantages of oophorectomy, covering various aspects such as ovarian cancer risk, myocardial infarction incidence, and post-oophorectomy peritoneal cancer, there is a notable absence of a comprehensive evaluation system for risk stratification. The objective of the present paper is to address this gap by consolidating existing literature into a risk stratification system. This system will provide treating physicians a tool that facilitates more informed, case-specific decisions in collaboration with patients and their families. While recognizing that the ultimate decision must be tailored to the individual case and agreed upon mutually by the surgeon, patient, and family, the proposed system seeks to streamline risk stratification. This, in turn, should aid in determining the most suitable course of treatment that maximizes benefits for the patient.
Literatur
1.
Zurück zum Zitat Asfour V, Jakes AD, et al. Oophorectomy or ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynaecol. 2022;24:131–6.CrossRef Asfour V, Jakes AD, et al. Oophorectomy or ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynaecol. 2022;24:131–6.CrossRef
2.
Zurück zum Zitat NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Version 2.2024—September 27, 2023 NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Version 2.2024—September 27, 2023
3.
Zurück zum Zitat Lim M, Pfaendler K. Type and risk of cancer related to endometriosis: ovarian cancer and beyond. BJOG Int J Obstet Gy. 2018;125:73–73.CrossRef Lim M, Pfaendler K. Type and risk of cancer related to endometriosis: ovarian cancer and beyond. BJOG Int J Obstet Gy. 2018;125:73–73.CrossRef
4.
Zurück zum Zitat Fogle RH, Stanczyk FZ, et al. Ovarian Androgen Production in Postmenopausal Women. J Clin Endocrinol Metab. 2007;92(8):3040–3.CrossRefPubMed Fogle RH, Stanczyk FZ, et al. Ovarian Androgen Production in Postmenopausal Women. J Clin Endocrinol Metab. 2007;92(8):3040–3.CrossRefPubMed
5.
Zurück zum Zitat Hendrix SL. Bilateral oophorectomy and premature menopause. Am J Med. 2005;118(12B):131S-135S.CrossRef Hendrix SL. Bilateral oophorectomy and premature menopause. Am J Med. 2005;118(12B):131S-135S.CrossRef
6.
Zurück zum Zitat Erekson EA, et al. Oophorectomy: the debate between ovarian conservation and elective oophorectomy. Menopause (New York, NY). 2013;20(1):110–4.CrossRefPubMed Erekson EA, et al. Oophorectomy: the debate between ovarian conservation and elective oophorectomy. Menopause (New York, NY). 2013;20(1):110–4.CrossRefPubMed
7.
Zurück zum Zitat Parker WH, Jacoby V, et al. Effect of bilateral oophorectomy on women’s long-term health. Women’s Health. 2009;5(5):565–76.PubMed Parker WH, Jacoby V, et al. Effect of bilateral oophorectomy on women’s long-term health. Women’s Health. 2009;5(5):565–76.PubMed
8.
Zurück zum Zitat Lafferty, et al. Ovarian remnant syndrome: Experience at Jackson Hospital, University of Miami, 1985 through 1993. Am J Obstet Gynecol. 1996;174:641–5.CrossRefPubMed Lafferty, et al. Ovarian remnant syndrome: Experience at Jackson Hospital, University of Miami, 1985 through 1993. Am J Obstet Gynecol. 1996;174:641–5.CrossRefPubMed
9.
Zurück zum Zitat Stuursma A, van der Vegt B, et al. The effect of risk-reducing salpingo-oophorectomy on breast cancer incidence and histopathological features in women with a BRCA1 or BRCA2 germline pathogenic variant. Cancers. 2023;15(7):2095.CrossRefPubMedPubMedCentral Stuursma A, van der Vegt B, et al. The effect of risk-reducing salpingo-oophorectomy on breast cancer incidence and histopathological features in women with a BRCA1 or BRCA2 germline pathogenic variant. Cancers. 2023;15(7):2095.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Oseledchyk A, Gemignani ML, Zhou QC, et al. Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients. Int J Gynecol Cancer. 2021;31:222–31.CrossRefPubMed Oseledchyk A, Gemignani ML, Zhou QC, et al. Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients. Int J Gynecol Cancer. 2021;31:222–31.CrossRefPubMed
11.
Zurück zum Zitat Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention | ACOG. Committee Opinion Number 774, April 2019 Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention | ACOG. Committee Opinion Number 774, April 2019
12.
Zurück zum Zitat Tschernichovsky R, Goodman A. Risk-reducing strategies for ovarian cancer in BRCA mutation carriers: a balancing act. Oncologist. 2017;22(4):450–9.CrossRefPubMedPubMedCentral Tschernichovsky R, Goodman A. Risk-reducing strategies for ovarian cancer in BRCA mutation carriers: a balancing act. Oncologist. 2017;22(4):450–9.CrossRefPubMedPubMedCentral
Metadaten
Titel
OOPHORECTOMY: When and Why? A Novel Risk Stratification Tool as an Aid to Decision Making at Gynecological Surgeries
verfasst von
Suvarna Satish Khadilkar
Meena Samant
Publikationsdatum
19.12.2023
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 6/2023
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-023-01924-y

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Fünf Faktoren sagen Lymphödeme nach Brustkrebs voraus

Ob nach der operativen Behandlung von Brustkrebs ein Lymphödem droht, lässt sich anhand eines Risikomodells abschätzen, das auf fünf leicht verfügbaren klinischen Parametern beruht.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den Arbeitsaufwand für Radiologen. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

Präeklampsie-Prophylaxe mit ASS: Suche nach optimaler Dosierung

Der Nutzen einer frühzeitigen Präeklampsie-Prophylaxe mit Acetylsalicylsäure steht außer Frage. Über die optimale Dosierung wird noch diskutiert. Eine Forschungsgruppe aus Schweden hat deshalb verschiedene Einnahmeregime verglichen, mit einem erstaunlichem Ergebnis.

Automatisierte Insulinabgabe hilft postpartal bei Blutzuckerkontrolle

Ergebnisse aus einer Fortsetzung der AiDAPT-Studie sprechen dafür, dass ein HCL („hybrid closed loop“)-System auch in den ersten sechs Monaten nach dem Entbinden eine bessere Blutzuckereinstellung erlaubt als eine Standardinsulinabgabe.  

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.